Literature DB >> 27844194

[Implantable sensors for outpatient assessment of ventricular filling pressure in advanced heart failure : Which telemonitoring design is optimal?]

E Herrmann1, S Fichtlscherer2, S H Hohnloser2, A M Zeiher2, B Aßmus2.   

Abstract

INTRODUCTION: Patients with advanced heart failure suffer from frequent hospitalizations. Non-invasive hemodynamic telemonitoring for assessment of ventricular filling pressure has been shown to reduce hospitalizations. We report on the right ventricular (RVP), the pulmonary artery (PAP) and the left atrial pressure (LAP) sensor for non-invasive assessment of the ventricular filling pressure.
METHODS: A literature search concerning the available implantable pressure sensors for noninvasive haemodynamic telemonitoring in patients with advanced heart failure was performed.
RESULTS: Until now, only implantation of the PAP-sensor was able to reduce hospitalizations for cardiac decompensation and to improve quality of life. The right ventricular pressure sensor missed the primary endpoint of a significant reduction of hospitalizations, clinical data using the left atrial pressure sensor are still pending.
CONCLUSION: The implantation of a pressure sensor for assessment of pulmonary artery filling pressure is suitable for reducing hospitalizations for heart failure and for improving quality of life in patients with advanced heart failure.

Entities:  

Keywords:  Cardiac decompensation; Chronic heart failure; Hospitalisation; Pressure sensor; Telemonitoring

Mesh:

Year:  2016        PMID: 27844194     DOI: 10.1007/s00399-016-0472-0

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  13 in total

1.  CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.

Authors:  Philip B Adamson; William T Abraham; Mark Aaron; Juan M Aranda; Robert C Bourge; Andrew Smith; Lynne W Stevenson; Jordan G Bauman; Jay S Yadav
Journal:  J Card Fail       Date:  2011-01       Impact factor: 5.712

Review 2.  Trials of implantable monitoring devices in heart failure: which design is optimal?

Authors:  William T Abraham; Wendy G Stough; Ileana L Piña; Cecilia Linde; Jeffrey S Borer; Gaetano M De Ferrari; Roxana Mehran; Kenneth M Stein; Alphons Vincent; Jay S Yadav; Stefan D Anker; Faiez Zannad
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

3.  Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.

Authors:  Maria R Costanzo; Lynne W Stevenson; Philip B Adamson; Akshay S Desai; J Thomas Heywood; Robert C Bourge; Jordan Bauman; William T Abraham
Journal:  JACC Heart Fail       Date:  2016-02-10       Impact factor: 12.035

4.  Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure.

Authors:  Anthony Magalski; Philip Adamson; Frederick Gadler; Michael Böehm; David Steinhaus; Dwight Reynolds; Kathryn Vlach; Cecilia Linde; Bodo Cremers; Brandon Sparks; Tom Bennett
Journal:  J Card Fail       Date:  2002-04       Impact factor: 5.712

5.  Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system.

Authors:  Philip B Adamson; Anthony Magalski; Frieder Braunschweig; Michael Böhm; Dwight Reynolds; David Steinhaus; Allyson Luby; Cecilia Linde; Lars Ryden; Bodo Cremers; Teri Takle; Tom Bennett
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

6.  Case management program for patients with chronic heart failure: effectiveness in terms of mortality, hospital admissions and costs.

Authors:  Verena Hendricks; Simone Schmidt; Achim Vogt; Detlef Gysan; Volker Latz; Ines Schwang; Reinhard Griebenow; Rainer Riedel
Journal:  Dtsch Arztebl Int       Date:  2014-04-11       Impact factor: 5.594

7.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.

Authors:  Robert C Bourge; William T Abraham; Philip B Adamson; Mark F Aaron; Juan M Aranda; Anthony Magalski; Michael R Zile; Andrew L Smith; Frank W Smart; Mark A O'Shaughnessy; Mariell L Jessup; Brandon Sparks; David L Naftel; Lynne Warner Stevenson
Journal:  J Am Coll Cardiol       Date:  2008-03-18       Impact factor: 24.094

8.  Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.

Authors:  William T Abraham; Lynne W Stevenson; Robert C Bourge; Jo Ann Lindenfeld; Jordan G Bauman; Philip B Adamson
Journal:  Lancet       Date:  2015-11-09       Impact factor: 79.321

9.  Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device.

Authors:  Jay Ritzema; Iain C Melton; A Mark Richards; Ian G Crozier; Chris Frampton; Robert N Doughty; James Whiting; Saibal Kar; Neal Eigler; Henry Krum; William T Abraham; Richard W Troughton
Journal:  Circulation       Date:  2007-12-03       Impact factor: 29.690

10.  Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance.

Authors:  Richard W Troughton; Jay Ritzema; Neal L Eigler; Iain C Melton; Henry Krum; Philip B Adamson; Saibal Kar; Prediman K Shah; James S Whiting; J Thomas Heywood; Spencer Rosero; Jagmeet P Singh; Leslie Saxon; Ray Matthews; Ian G Crozier; William T Abraham
Journal:  J Cardiovasc Transl Res       Date:  2010-10-14       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.